Skip to content

Low Level Laser Therapy and Interferential Current in Osteoarthritis

Low Level Laser Therapy and Interferential Current in Patients With Knee Osteoarthritis: Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02898025
Enrollment
168
Registered
2016-09-13
Start date
2015-11-30
Completion date
2017-08-31
Last updated
2017-10-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis

Brief summary

This study aims to evaluate the effectiveness of the low level laser therapy and interferential current in 168 patients with knee osteoarthritis

Detailed description

Interventional

Interventions

DEVICEActive Interferential Current

Involves the application of medium frequency alternating currents

Involves the application of low level laser over the knee

It is a sham interferential therapy

DEVICEPlacebo Laser

It is a sham laser therapy

Sponsors

Universidade Cidade de Sao Paulo
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* History of osteoarthritis of the knee characterized by pain of mild or moderate intensity * Radiographic evidence of grade 2 or 3 osteoarthritis based on the Kellgren and Lawrence radiographic entry criteria * Patients with knee osteoarthritis (s) according to the ACR criteria * VAS 3 to 8 * 5 to 12 Lequesne * No complaint of pain in other joints of the lower limbs * Without neurological and cognitive disorders * No loss of sensation in the lower limbs * No surgery on the knee (s) in the last 6 months * Pain symptoms for at least 6 months * No infiltrations (s) knee (s) in the last 4 weeks * No use of analgesics 4 hours before treatment

Exclusion criteria

* Individuals younger than 18 and older than 80 years * Complaints from other diseases of the lower limbs, knee prosthesis and / or hip joint instabilities and / or surgery in lower limbs, heart disease, uncontrolled hypertension and diabetes, coagulation disorders in anticoagulant therapy, pregnant women, fibromyalgia and individuals who can not perform isokinetic test who have difficulty performing the TUG, and those that are experiencing abnormal sensitivity to algometry

Design outcomes

Primary

MeasureTime frame
Pain intensity measured by a numeric pain scale ranging from 0 to 10.4 weeks
Pressure Pain Threshold measured by a pressure algometer. Pressure will be recorded in kPa.4 weeks

Secondary

MeasureTime frame
TUG (Timed Up & Go Test)Measure at baseline, 4 weeks, 3 months, 6 months
Isokinetic Muscle AssessmentMeasure at baseline, 4 weeks, 3 months, 6 months
LeQuesne QuestionnaireMeasure at baseline, 4 weeks, 3 months, 6 months
WOMAC (Western Ontario and McMaster Universities Arthritis Index)Measure at baseline, 4 weeks, 3 months, 6 months

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 24, 2026